Increased energy, clarity of mind and curbbed appetite
The incretin mimetics, glucagon-like peptide-1 receptor agonists (eg, semaglutide, liraglutide) and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist (ie, tirzepatide), demonstrate the greatest weight loss benefits, with tirzepatide achieving reductions exceeding 20% in some patients
LaRocca and the LaRocca Medical Team Not a Current Patient
A study involving mice also found that the release of free copper ions induced neointimal thickening and contributed to the development of atherosclerotic lesions in damaged rat carotid arteries (62)
SLU-PP-332 is used in research laboratories to investigate cellular signaling, metabolic pathways, and receptor activity
Some patients find it helpful to inject in the evening so the initial peak occurs during sleep, reducing awareness of mild GI discomfort